2021. RFLSP.Russian.Finnish.Life.Science.Industry.EN

1.1.6 Export of Russian pharmaceutical products
Despite the fact that the Russian pharmaceutical industry is currently underrepresented in
the international market, Russian enterprises are consistently increasing the volume of
export supplies (over the past 8 years, the decline was observed only in 2015). According to
the Russian Export Center, at the end of 2020, the export of pharmaceutical products from
the Russian Federation amounted to USD 1,058 million (an increase of 24.54% compared to
2019). Pharmaceutical products are ranked 27th in the ranking of Russian exported goods in
terms of export volume with a share of 0.31%. The main sales markets for Russian
pharmaceutical products are Kazakhstan, Ukraine, Belarus. The key exporting regions of
pharmaceutical products are Moscow, Moscow Region, Nizhny Novgorod Region, St.
Petersburg, and Rostov Region. 7
Dynamics of export volumes of pharmaceutical products in the
Russian Federation, USD mln
(+24.54%)
589 (+5.07%)
(-11.63%)
(+16.63%)
(15.12%)
(+8.23%)
(+7%)
2013 2014 2015 2016 2017 2018 2019 2020
Source: Analytical portal “Export of Regions” JSC “Russian Export Center”
According to the draft Strategy “Pharma-2030”, the export volume of medicines (excluding
other pharmaceutical products), in case of implementation of support measures, may reach
USD 3,800 million. The draft Strategy lists the main factors that can contribute to the
achievement of this ambitious goal, the risks that need to be taken into account and the
priorities for future support programs.
The end of the patent protection period for original biological products and the appearance
of biosimilars falls on 2019-2022. This trend is one of the key factors of the potential for
entering foreign markets with analogues of medicines, especially biotechnological ones.
7
Analytical portal “Export of Regions” JSC “Russian Export Center”: www.regionstat.exportcenter.ru.
RUSSIAN-FINNISH LIFE SCIENCE INDUSTRY
Research and export directory
23